Morgado, Felipe http://orcid.org/0000-0003-3000-9455
Vandewouw, Marlee M.
Hammill, Christopher
Kelley, Elizabeth http://orcid.org/0000-0001-7742-6542
Crosbie, Jennifer
Schachar, Russell
Ayub, Muhammad http://orcid.org/0000-0002-7111-1571
Nicolson, Robert http://orcid.org/0000-0001-7086-7038
Georgiades, Stelios
Arnold, Paul http://orcid.org/0000-0003-2496-4624
Iaboni, Alana
Kushki, Azadeh http://orcid.org/0000-0003-1510-8818
Taylor, Margot J.
Anagnostou, Evdokia
Lerch, Jason P.
Funding for this research was provided by:
Council of Ontario Universities
Fondation Brain Canada
Ontario Brain Institute
Article History
Received: 8 November 2022
Revised: 27 February 2024
Accepted: 29 February 2024
First Online: 3 April 2024
Competing interests
: E. Anagnostou has served as a consultant to Roche, Quadrant Therapeutics and Impel Pharmaceuticals, holds a patent for the device, “Anxiety Meter”, and has received in kind support from AMO pharma and CRA, royalties from APPI and Springer, and editorial honoraria from Wiley. A. Kushki holds a patent for the device, “Anxiety Meter”, and has received consulting fees from DNAStack and Shaftesbury.